Evaluation of the risk of contamination of surgical personnel by vaporization of oxaliplatin during the intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC)
- 30 June 2007
- journal article
- Published by Elsevier BV in European Journal of Surgical Oncology
- Vol. 33 (5), 623-626
- https://doi.org/10.1016/j.ejso.2007.02.027
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Investigations on safety of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with Mitomycin CEuropean Journal of Surgical Oncology, 2006
- The approval process for hyperthermic intraoperative intraperitoneal chemotherapyEuropean Journal of Surgical Oncology, 2006
- Heated intra-operative intraperitoneal oxaliplatin alone and in combination with intraperitoneal irinotecan: Pharmacologic studiesEuropean Journal of Surgical Oncology, 2006
- Assessing contamination paths of the German adult population with gold and platinum. The German Environmental Survey 1998 (GerES III)International Journal of Hygiene and Environmental Health, 2005
- Metal and metalloid multi-elementary ICP-MS validation in whole blood, plasma, urine and hairForensic Science International, 2005
- OxaliplatinDrugs, 2003
- Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesotheliomaEuropean Journal of Surgical Oncology, 2002
- Determination of the vaporization of solutions of mutagenic antineoplastic agents at 23 and 37°C using a desiccator techniqueMutation Research - Genetic Toxicology and Environmental Mutagenesis, 2000
- Determination of platinum in workroom air and in blood and urine from nursing staff attending patients receiving cisplatin chemotherapyInternationales Archiv für Arbeitsmedizin, 1997
- Monitoring occupational exposure to cancer chemotherapy drugsAmerican Journal of Health-System Pharmacy, 1996